Prenatal screening for HIV can inform use of interventions to reduce the risk of mother-to-child transmission. The US Preventive Services Task Force (USPSTF) previously found strong evidence that prenatal HIV screening reduced risk of mother-to-child transmission. The previous evidence review was conducted in 2012.
Jeff Craven has written an interesting article in Ob.Gyne.News about shorter interpregnancy intervals and the possibility of adverse outcomes.
In low-risk nulliparous women, compared with expectant management, labor induction at 39 weeks was associated with lower likelihood of cesarean delivery.
Allison Bryant, MD, MPH, reviews a study by Grobman WA et al. (N Engl J Med 2018 Aug 9) in the New England Journal of Medicine that these long-awaited data convincingly demonstrate that labor induction at 39 weeks’ gestation (in the absence of medical indications for delivery) does not result in harm, including excess risk for cesarean delivery — at least among women similar to the trial participants.
This article appears in the May 2018 Issue of Obstetrics & Gynecology. You can access the article by clicking HERE.
The objective of the study was to evaluate the transfer of delta-9-tetrahydrocannabinol and its metabolites into human breast milk after maternal inhalation of 0.1 g cannabis containing 23.18% delta-9-tetrahydrocannabinol. (In clear language – what’s the effect of smoking pot on your breast milk?)
This study documents inhaled delta-9-tetrahydrocannabinol transfer into the mother’s breast milk. Low concentrations of delta-9-tetrahydrocannabinol were detected. The long-term neurobehavioral effect of exposure to delta-9-tetrahydrocannabinol on the developing brain is unclear. Mothers should be cautious using cannabis during pregnancy and breastfeeding.
In short – if you smoke pot, this study indicates it will get into your breast milk.
Factors influencing repeated teenage pregnancy: a review and meta-analysis
Existing evidence of predictors of repeated teenage pregnancy has not been assessed rigorously. This systematic review provides a comprehensive evaluation of protective and risk factors that are associated with repeated teenage pregnancy through a metaanalytical consensus
Presented at the 15th World Congress on Public Health, Melbourne, Australia, April 3-7, 2017 by
Joemer C. Maravilla, RN, James C. Maravilla, RN, Kim S. Betts, PhD, Rosa Alati, Phd, and Camila Couto e Crus
Kari Oakes reports in Ob.Gyn.News that a woman with a transplanted uterus gave birth to a live baby boy in Dallas, the first birth from a transplanted uterus in the United States. It is also the first birth resulting from uterine transplantation to be performed outside of Sweden, where a total of eight births have occurred.
Alicia Gallegos writes an article in Ob.Gyn.News about the proposal to limit birth control access.
Gemma Francis writes an interesting article in Independent Life about a special day – January 17.
Kari Oakes writes an interesting article published in the October 14, 2017 issue of OB.Gyn News that it is time to take the fear out of the hormone therapy conversation.
“I want to take fear out of the conversation. Hormone therapy remains the most effective treatment for vasomotor symptoms and the genitourinary syndrome of menopause and has been shown to prevent bone loss and fracture,” said Dr. JoAnn Pinkerton, who also chaired the advisory panel that penned the 2017 NAMS position statement on hormone therapy.